Showing results (1561-1570 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|August 2, 2008
Caffeine and progression of Parkinson diseaseDavid K Simon, Christopher J Swearingen, Robert A Hauser, et al.Clinical Neuropharmacology|August 2, 2008
Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case seriesLeonilda Bilo, Roberta Meo, Maria Fulvia de Leva, et al.Clinical Neuropharmacology|August 2, 2008
Remission of migraine attacks in a patient with depression who is taking pregabalinVasilios G Masdrakis, Panagiotis Oulis, Nikolaos A Karakatsanis, et al.Clinical Neuropharmacology|August 2, 2008
Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: treatment with pregabalinHortensia Alonso-Navarro, Angel Fernández-Díaz, Manuela Martín-Prieto, et al.Clinical Neuropharmacology|August 2, 2008
Adjunctive use of methylphenidate in the treatment of psychotic unipolar depressionChang-Chih Huang, I-Shin Shiah, Hsing-Kang Chen, et al.Clinical Neuropharmacology|August 2, 2008
Late-life somnambulism after therapy with metoprololJutta Hensel, Frank PillmannClinical Neuropharmacology|December 4, 2008
Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy centerMaria A Montenegro, Hiba Arif, Edmund A Nahm, et al.Clinical Neuropharmacology|December 4, 2008
Role of sildenafil in neurological disordersMuhammad U Farooq, Bharath Naravetla, Philip W Moore, et al.Clinical Neuropharmacology|December 4, 2008
Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministrationPanagiotis Oulis, Constantin Potagas, Vasilios G Masdrakis, et al.Clinical Neuropharmacology|November 4, 2008
Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's diseaseDebra Tompson, Ruth Oliver-WillwongPageof 237